Xvivo Perfusion AB Performance

XVIPYDelisted Stock  USD 5.70  0.53  8.51%   
The firm maintains a market beta of -0.2, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Xvivo Perfusion are expected to decrease at a much lower rate. During the bear market, Xvivo Perfusion is likely to outperform the market. Xvivo Perfusion AB right now maintains a risk of 0.0%. Please check out Xvivo Perfusion AB jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Xvivo Perfusion AB will be following its historical returns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Xvivo Perfusion is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
  

Xvivo Perfusion Relative Risk vs. Return Landscape

If you would invest  570.00  in Xvivo Perfusion AB on November 24, 2025 and sell it today you would earn a total of  0.00  from holding Xvivo Perfusion AB or generate 0.0% return on investment over 90 days. Xvivo Perfusion AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Xvivo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Xvivo Perfusion Target Price Odds to finish over Current Price

The tendency of Xvivo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.70 90 days 5.70 
close to 99
Based on a normal probability distribution, the odds of Xvivo Perfusion to move above the current price in 90 days from now is close to 99 (This Xvivo Perfusion AB probability density function shows the probability of Xvivo Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Xvivo Perfusion AB has a beta of -0.2. This entails as returns on the benchmark increase, returns on holding Xvivo Perfusion are expected to decrease at a much lower rate. During a bear market, however, Xvivo Perfusion AB is likely to outperform the market. Additionally Xvivo Perfusion AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Xvivo Perfusion Price Density   
       Price  

Predictive Modules for Xvivo Perfusion

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xvivo Perfusion AB. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
5.705.705.70
Details
Intrinsic
Valuation
LowRealHigh
5.425.426.27
Details
Naive
Forecast
LowNextHigh
4.924.924.92
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-11.677.5026.67
Details

Xvivo Perfusion Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Xvivo Perfusion is not an exception. The market had few large corrections towards the Xvivo Perfusion's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Xvivo Perfusion AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Xvivo Perfusion within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.84
β
Beta against Dow Jones-0.2
σ
Overall volatility
1.39
Ir
Information ratio -0.2

Xvivo Perfusion Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Xvivo Perfusion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Xvivo Perfusion AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Xvivo Perfusion AB is not yet fully synchronised with the market data
Xvivo Perfusion AB has a very high chance of going through financial distress in the upcoming years
Xvivo Perfusion generates negative cash flow from operations

Xvivo Perfusion Fundamentals Growth

Xvivo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Xvivo Perfusion, and Xvivo Perfusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xvivo Pink Sheet performance.

About Xvivo Perfusion Performance

Evaluating Xvivo Perfusion's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Xvivo Perfusion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xvivo Perfusion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion is traded on OTC Exchange in the United States.

Things to note about Xvivo Perfusion AB performance evaluation

Checking the ongoing alerts about Xvivo Perfusion for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Xvivo Perfusion AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Xvivo Perfusion AB is not yet fully synchronised with the market data
Xvivo Perfusion AB has a very high chance of going through financial distress in the upcoming years
Xvivo Perfusion generates negative cash flow from operations
Evaluating Xvivo Perfusion's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Xvivo Perfusion's pink sheet performance include:
  • Analyzing Xvivo Perfusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xvivo Perfusion's stock is overvalued or undervalued compared to its peers.
  • Examining Xvivo Perfusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Xvivo Perfusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xvivo Perfusion's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Xvivo Perfusion's pink sheet. These opinions can provide insight into Xvivo Perfusion's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Xvivo Perfusion's pink sheet performance is not an exact science, and many factors can impact Xvivo Perfusion's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Xvivo Pink Sheet

If you are still planning to invest in Xvivo Perfusion AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xvivo Perfusion's history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets